Brad Ausmus

2014 Preview: Detroit Tigers

16 Comments

Between now and Opening Day, HardballTalk will take a look at each of baseball’s 30 teams, asking the key questions, the not-so-key questions, and generally breaking down their chances for the 2014 season. Next up: The Detroit Tigers.

The Big Question: Are the Tigers still the clear favorites in the AL Central?

Detroit has won three consecutive AL Central titles, but the margin of victory was just one game last season and the Tigers made some huge changes over the offseason in an effort to improve their bullpen and defense while shedding long-term payroll. Gone are Prince Fielder, Doug Fister, Jhonny Peralta, Omar Infante, and Joaquin Benoit, plus manager Jim Leyland.

Fielder was traded to the Rangers in a move that brought in Kinsler to replace Infante at second base and cleared the way for Miguel Cabrera to slide across the diamond from third base to first base. Top prospect Nick Castellanos replaces Cabrera at third base as the Tigers count on him to be a key contributor as a 22-year-old rookie and ask him to move back to the infield after spending last season playing left field in the minors. That series of moves represents a massive shift in the type of team the Tigers are putting on the field under new manager Handsome Brad Ausmus.

Detroit’s haul from Washington for Fister was largely criticized for being not enough, but he was the Tigers’ fourth-best starter and they also felt Drew Smyly was ready for another chance in the rotation after thriving as a reliever last year. Benoit had an excellent three-season run in Detroit, but in bringing in the still dominant at 39 years old Nathan the Tigers are hoping that he can solidify the ninth inning while allowing the rest of the bullpen to fall into place.

One snag in the Tigers’ plans is slick-fielding Jose Iglesias, who was supposed to be the anchor of the much-improved defense and will instead miss the first half and possibly the entire season with stress fractures in both shins. In scrambling to replace him with 37-year-old Alex Gonzalez the Tigers overpaid for a seemingly washed-up player and likely put themselves in position to go shopping for a different replacement in a couple months.

Still, this is a much better team defensively, with a lot more speed, and if Castellanos lives up to the hype and they can piece together decent production in left field the offense is still plenty potent even without Fielder around. They just signed the world’s best hitter to a decade-long extension, after all. Getting the ball from the starters to Nathan may be an issue, but if everyone stays healthy the rotation remains one of the best in baseball with the reigning Cy Young winner in the No. 2 slot and the reigning ERA champ in the No. 3 slot. If the Indians or Royals had made big improvements this offeason the division could be totally up for grabs, but instead Detroit still looks like the clear-cut favorite for a fourth straight year.

What else is going on?

  • This is easier to say now that Fister is injured, but Smyly has a chance to be nearly as good for the Tigers’ rotation. As a reliever last year he threw 76 innings with a 2.37 ERA and 81/17 K/BB ratio, and as a 23-year-old rookie starter in 2012 he logged 99 innings with a 3.99 ERA and 94/33 K/BB ratio. Fister was really good and really underrated in his 2.5 seasons in Detroit, but Smyly throws strikes, has bat-missing raw stuff, and can be an impact starter.
  • Left-handed-hitting Andy Dirks and right-handed-hitting Rajai Davis were supposed to form a platoon in left field, but now Dirks is out for three months following back surgery. That pushes Davis into an expanded role, which will be good for the Tigers’ speed and defense, but he’s likely to struggle facing lots of right-handed pitching and left field is an area where general manager Dave Dombrowski may look to make a move midseason.
  • Home/road splits are far from the final word in projecting a player who’s changing teams, but it’s worth noting that Kinsler is a career .304 hitter with an .898 OPS in hitter-friendly Texas compared to .242 with a .710 OPS everywhere else. Toss in his overall decline recently as he crossed over into the wrong side of 30 and what to expect from Kinsler is a big question mark.

Prediction: Better defense, worse hitting, and another 90-win season. First place, AL Central.

Marlins acquire starter Dan Straily from the Reds

CINCINNATI, OH - SEPTEMBER 3: Dan Straily #58 of the Cincinnati Reds throws a pitch during the first inning of the game against the St. Louis Cardinals at Great American Ball Park on September 3, 2016 in Cincinnati, Ohio. (Photo by John Sommers II/Getty Images)
Getty Images
1 Comment

The Miami Marlins have acquired starting pitcher Dan Straily from the Cincinnati Reds. In exchange, the Reds will receive right-handed pitching prospects Luis Castillo and Austin Brice and outfield prospect Isaiah White.

For the Marlins, they get a solid starter who logged 191.1 innings of 113 ERA+ ball last year. Straily has moved around a lot in his five big league seasons — the Marlins will be his fifth club in six years — but it was something of a breakout year for him in Cincinnati. The only troubling thing: he tied for the league lead in homers allowed. Of course, pitching half of his games in Great American Ballpark didn’t help that, and Miami will be a better place for him.

Castillo is 24. He split last season between high-A and Double-A — far more of it in A-ball — posting a 2.26 ERA over 24 starts. Austin Brice is also 24. He pitched 15 games in relief for the Marlins last year at the big league level with poor results. He seemed to blossom at Triple-A, however, after the Marlins shifted him to the pen. White was a third round pick in the 2015 draft. He played low-A ball as a minor leaguer last year, hitting .214/.306/.301.

A mixed bag of young talent for the Reds, but stockpiling kids and seeing what shakes out is what a team like the Reds should be doing at the moment. For the Marlins: a solid mid-to-back end starter who may just be coming into his own.

Have Hall of Fame Voters actually made the PED thing More complicated?

Sammy Sosa
Associated Press
7 Comments

The story coming out of this year’s Hall of Fame balloting is that the BBWAA voters are finally easing their antipathy toward players with performance enhancing drug associations.

Jeff Bagwell — the subject of unconfirmed PED rumors — made the Hall! Pudge Rodriguez, who was named in Jose Canseco’s book and who had a . . . curious physical transformation around the time PED testing came online, made it on the first ballot! Barry Bonds and Roger Clemens, whose PED use was well-documented, saw their vote totals advance above the 50% mark, making their future elections look more likely!

It’s an interesting development, and one I’m obviously pleased with, but I wonder if the BBWAA’s new approach to PED guys, while far more forgiving than it used to be, has actually become more complicated in practice.

I ask this because I look way, way down the ballot and I still see Sammy Sosa scraping by with around 8% of the vote. I ask this because I still see Gary Sheffield at 13%. I ask this because when Mark McGwire was on the Today’s Game ballot in December, no one really stumped for him at all. I ask this because, even though Bagwell and Mike Piazza got in eventually, they still had to go through a lot of hazing first and I suspect, if they hit the ballot for the first time again tomorrow, the same arguments and delay would occur with respect to their cases.

In light of that, what I suspect has happened has not been a wholesale surrender of the anti-PED voters. Rather, I think it has been a transformation. One in which a moral test — did he use PEDs or not? — has been discarded as a threshold question and a scientific/physiological test — would he have been great even without the PEDs? — has replaced it. In essence, voters are becoming “PED discounters” in the aggregate. Making calculations as to whether a guy was, in their mind, a creation of PEDs or not.

Such an approach explains these new voting patterns as well as those in recent years.

  • Ivan Rodriguez may have been called out by Canseco and may have noticeably shrunk over an offseason, but his calling card was his defense behind the plate and voters, I suspect, have told themselves that such a thing is not PED-aided.
  • Bonds and Clemens may have been PED users, but each of them was undeniably talented and, if you discount for the PED use, hey, they’re still all-time greats.
  • Sammy Sosa’s case rests disproportionately on homers and, as everyone knows, PEDs = instant dingers, so no, he’s not gonna cut it.

And so on.

As I said, I’m glad that the strict moral test — did he use or not? — is losing its hold on Hall voters. But I do not think the “did PEDs make him who he was test?” is a good approach either. Baseball writers are in no better a position to assess the physiological and performance enhancements caused by pharmaceuticals than they are to be judges of character and morality. Given the identities of players confirmed to be PED users, the old eye test implicit in these cases is famously faulty (Neifi Perez, anyone?). The idea that PEDs only affect home run totals — and not, say, the ability for a player to take the abuse of the catcher position for 21 seasons — is crude and ignorant.

I suppose it’s naive to expect voters to completely disregard PEDs in their assessment of players. It’s a bell that cannot be unrung. But while we may, thankfully, be moving away from a moral test with respect to drugs, it’s been displaced by a scientific test that is no more reasonable in practice.